Safety and Quality Improvement
American College of Radiology (ACR) Accreditation
The Genesys Hurley Cancer Institute is accredited by the American College of Radiology. ACR Accreditation is recognized as the gold standard in medical imaging. ACR Accreditation assures our patients that we provide the highest level of image quality and safety by documenting that our facility meets requirements for equipment, medical personnel and quality assurance. Read More
Safety and Quality Improvement
As part of our quality improvement program we are enrolled in Radiation Oncology Incident Learning System (RO-ILS) . RO-ILS is a national database sponsored by ASTRO and the AAPM and dedicated to improving patient safety by collecting and analyzing treatment-related incidents. This has been a part of the CQI program since 2017.
Peer Review and Morning Huddle Meetings
As the complexity of radiation treatments continues to increase, peer review is a vital component to ensure patient safety and accurate treatment delivery. Physicians, physics, dosimetry, and radiation therapists attend a weekly meeting to review all patient treatment plans. Upon review of the treatment plans, adjustments are made based on physician recommendations and the National Comprehensive Cancer Network (NCCN) guidelines.
The daily morning huddle allows our team to address quality and safety concerns, review treatment checklists, and improve inter-department coordination. Morning huddles are a venue to ensure department issues are handled proactively.
National Quality and Safety Initiatives
The Genesys Hurley Cancer Institute is a proud member of the Michigan Radiation Oncology Quality Consortium (MROQC). MROQC is a collaborative group of specialists across the state of Michigan working together on quality improvement projects to impact the radiation treatment experience for patients. MROQC’s goal is to identify best practices in radiation therapy that minimize the side effects that patients may experience from radiation treatment. Read More
The Genesys Hurley Cancer Institute is a component site of Michigan Cancer Research Consortium-NCORP (MCRC-NCORP).
The MCRC-NCORP is a comprehensive clinical trial program that consists of medical centers that have met the highest standards of excellence in conducting cancer clinical trials. The MCRC-NCORP is one of 47 research programs established by the National Cancer Institute (NCI) to provide patients with access to national cancer research studies while remaining in their own communities. Read More
